Annovis Bio, Inc. Common Stock — 貸借対照表 (NYSE:ANVS) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 8.12 M46 M36.02 M10.21 M13.93 M21.08 M 負債合計 578.38 K1.51 M7.7 M17.96 M4.62 M4.23 M 純資産合計 7.54 M44.49 M28.32 M-7.75 M9.31 M16.85 M 負債および純資産合計 8.12 M46 M36.02 M10.21 M13.93 M21.08 M 有利子負債合計 —————— 純負債 ——————

ニュース

アノビス・バイオ、2026年1月にパーキンソン病薬の長期研究を開始へ

Annovis Bio to launch long-term Parkinson’s drug study in January

Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook

Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops

アノビス・バイオの取締役ホフマン氏、19万3,794ドル相当の株式を購入

Annovis Bio director Hoffman buys $193,794 in shares

Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling

アノビス・バイオの取締役ホフマン氏、ANVS株を6万9900ドル分購入

Annovis Bio director Hoffman buys $69.9k in ANVS stock

Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)

Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion

Annovis Bio raises $3.4 million in registered direct offering